HLSQ Share Price Performance
US$1.27
-88.92 (-98.59%)
99.2% undervalued intrinsic discount
US$165.00
Fair Value
Price US$1.27
AnalystConsensusTarget US$165.00
Fair ValueUS$165.00
Share Pricen/a
BiomX Inc. Stock Price
- 1 Narratives written by author
- 0 Comments on narratives written by author
- 9 Fair Values set on narratives written by author
HLSQ Community Narratives
AN
Fair Value
·Fair Value US$165 99.2% undervalued intrinsic discount
Regulatory Tailwinds And Antimicrobial Resistance Focus Will Support Long Term Phage Therapy Potential
0users have liked this narrative
0users have commented on this narrative
6users have followed this narrative
BiomX
99.2% undervalued intrinsic discount
Regulatory Tailwinds And Antimicrobial Resistance Focus Will Support Long Term Phage Therapy Potential
View narrativeAN
Published 5 Mar
Trending Discussion
No trending discussion available.
Recently Updated Narratives
AN
Regulatory Tailwinds And Antimicrobial Resistance Focus Will Support Long Term Phage Therapy Potential
Fair Value: US$165 99.2% undervalued intrinsic discount
6 fair values setusers have set this as their fair value
0 commentsusers have commented on this narrative
0 likesusers have liked this narrative
Snowflake Analysis
BiomX Inc. Key Details
Last Reported Earnings
Jun 30, 2026
Next Reporting Earnings
n/a
- -17.03
- 29.22%
- -13,704.82%
- 7.6%
About HLSQ
- Founded
- 2015
- Employees
- 20
- CEO
- WebsiteView website
BiomX Inc., a holding company, focuses on defense, security, and critical infrastructure technologies. The company’s portfolio targets various niches, such as counter-drone systems, AI-enabled command-and-control, perimeter and border security, wide-area surveillance, and aerial firefighting. It serves defense agencies, prime contractors, transportation operators, municipalities, and critical infrastructure providers. The company was founded in 2015 and is based in Dover, Delaware.
